Lexaria Bioscience Corp (LEXX)
2.87
-0.28
(-8.89%)
USD |
NASDAQ |
May 20, 14:23
Lexaria Bioscience Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| August 31, 2023 | 0.0486M |
| May 31, 2023 | 0.0486M |
| February 28, 2023 | 0.0693M |
| November 30, 2022 | 0.137M |
| August 31, 2022 | 0.0804M |
| May 31, 2022 | 0.0513M |
| February 28, 2022 | 0.019M |
| November 30, 2021 | 0.0073M |
| August 31, 2021 | 0.0166M |
| May 31, 2021 | 0.7849M |
| February 28, 2021 | 0.3943M |
| November 30, 2020 | 0.0038M |
| August 31, 2020 | 0.226M |
| May 31, 2020 | 0.1583M |
| February 29, 2020 | 0.1486M |
| November 30, 2019 | 0.1298M |
| August 31, 2019 | 0.1117M |
| May 31, 2019 | 0.1237M |
| February 28, 2019 | 0.0995M |
| November 30, 2018 | 0.1329M |
| August 31, 2018 | 0.2046M |
| May 31, 2018 | 0.2239M |
| February 28, 2018 | 0.1582M |
| November 30, 2017 | 0.0116M |
| August 31, 2017 | 0.0018M |
| Date | Value |
|---|---|
| May 31, 2017 | 0.0264M |
| February 28, 2017 | 0.0106M |
| November 30, 2016 | 0.01M |
| August 31, 2016 | 0.01M |
| May 31, 2016 | 0.0146M |
| February 29, 2016 | 0.0437M |
| November 30, 2015 | 0.0348M |
| August 31, 2015 | |
| May 31, 2015 | 0.0216M |
| February 28, 2015 | 0.035M |
| November 30, 2014 | 0.0753M |
| July 31, 2014 | 0.0987M |
| April 30, 2014 | 0.1003M |
| January 31, 2014 | 0.1307M |
| October 31, 2013 | 0.0385M |
| July 31, 2013 | 0.1518M |
| April 30, 2013 | 0.1672M |
| January 31, 2013 | 0.2399M |
| October 31, 2012 | 0.2909M |
| July 31, 2012 | 0.4979M |
| April 30, 2012 | 0.1395M |
| January 31, 2012 | 0.1764M |
| October 31, 2011 | 0.2309M |
| July 31, 2011 | 0.2316M |
| April 30, 2011 | 0.1705M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
0.0038M
Minimum
Nov 2020
0.7849M
Maximum
May 2021
0.1422M
Average
0.0961M
Median
Accounts Receivable (Quarterly) Benchmarks
| Sunshine Biopharma Inc | 2.552M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 24.09M |
| Edesa Biotech Inc | 1.112M |
| Xenon Pharmaceuticals Inc | 0.833M |